 | Up a level |
Jump to: 2016
Number of items: 1.
2016
Follows, G., Fischer, K., Bosch, F., Frederiksen, H., Cuneo, A., Ludwig, H., Crompton, N., Maurer, J., Uguen, M., Fingerle-Rowson, G., Hallek, M. and Goede, V. (2016). An updated survival analysis from the CLL11 study in patients with chronic lymphocytic leukaemia treated with obinutuzumab or rituximab in combination with chlorambucil versus chlorambucil alone. Br. J. Haematol., 173. S. 95 - 96. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141